Japan’s Sysmex Corp said on Thursday it has received regulatory approval in Japan for a blood test to detect amyloid beta in the brain, a hallmark of Alzheimer’s disease. The company developed the test with Japanese drugmaker Eisai Co and received approval from regulators on December 19, the company said in a statement. The test […]
